Correlation Engine 2.0
Clear Search sequence regions


  • Bub2 (1)
  • Cdc16 (1)
  • endocytosis (4)
  • humans (1)
  • influenza (3)
  • interferons (3)
  • RABGAP1L (6)
  • rna viruses (1)
  • sars cov (2)
  • small gtpases (1)
  • TBC (2)
  • Tre2 (1)
  • Sizes of these terms reflect their relevance to your search.

    Host interferons (IFNs) powerfully restrict viruses through the action of several hundred IFN-stimulated gene (ISG) products, many of which remain uncharacterized. Here, using RNAi screening, we identify several ISG restriction factors with previously undescribed contributions to IFN-mediated defense. Notably, RABGAP1L, a Tre2/Bub2/Cdc16 (TBC)-domain-containing protein involved in regulation of small membrane-bound GTPases, robustly potentiates IFN action against influenza A viruses (IAVs). Functional studies reveal that the catalytically active TBC domain of RABGAP1L promotes antiviral activity, and the RABGAP1L proximal interactome uncovered its association with proteins involved in endosomal sorting, maturation, and trafficking. In this regard, RABGAP1L overexpression is sufficient to disrupt endosomal function during IAV infection and restricts an early post-attachment, but pre-fusion, stage of IAV cell entry. Other RNA viruses that enter cells primarily via endocytosis are also impaired by RABGAP1L, while entry promiscuous SARS-CoV-2 is resistant. Our data highlight virus endocytosis as a key target for host defenses. Copyright © 2022 The Author(s). Published by Elsevier Inc. All rights reserved.

    Citation

    Sonja Fernbach, Eva E Spieler, Idoia Busnadiego, Umut Karakus, Anouk Lkharrazi, Silke Stertz, Benjamin G Hale. Restriction factor screening identifies RABGAP1L-mediated disruption of endocytosis as a host antiviral defense. Cell reports. 2022 Mar 22;38(12):110549

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 35320721

    View Full Text